Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Radiology provider Envision Healthcare considers handing control to creditors in bankruptcy

The multispecialty group—which employs about 500 radiologists—is exploring chapter 11 as it grapples with a heavy debt load. 

How the FDA’s approval process puts the safety of heart patients at risk

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

COVID-19 congress coronavirus Washington

Radiology among 120 medical societies announcing support for ‘broken’ Medicare pay system fix

“Organized medicine is united in support of a long-term payment solution," numerous national and state societies wrote to members of Congress. 

Thumbnail

Judge halts all lawsuits related to J&J talc formula

A U.S. judge halted all lawsuits against Johnson & Johnson over allegations that its talc formula products and baby powder contained cancer-causing asbestos, stopping any trials as the company has agreed to settle all claims for billions of dollars.

DOJ targets COVID-related healthcare fraud

One official described it as the 'largest-ever coordinated law enforcement action' of its kind.

GE Healthcare solution, billed as a 'unified approach to patient monitoring,' gains FDA clearance

GE Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for its patient monitoring platform, Carescape Canvas.

breast radiologist breast cancer mammography

Providers chart uptick in number of breast MRI denials issued by insurers

Among vulnerable women with BRCA1/2 mutations, about 14% never received this vital exam after the rejection, MSK researchers reported.

Thumbnail

Supreme Court delays final decision on abortion pill for 2 more days

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market.